[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis].

Article

[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis].

Neurologia i neurochirurgia polska - 1 Jan 2000

Milejski P, Orzechowska-Juzwenko K, Pawlik J, Kamienowski J, Horoch E, Niewiński P, Hurkacz M

Abstract excerpt

Genetically determined individual differences in the ability of oxidation and acetylation of certain drugs have raised in recent years a considerable interest in view of their clinical importance. The purpose of the study was finding out of a possible difference in the ability to oxidized spartei...

Topics

Acetylation
Adolescent
Adult
Aged
Female
Humans
Male
Middle Aged
Multiple Sclerosis
Oxidation-Reduction
Phenotype
Sparteine
Sulfamethazine

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.